Nexalin Technology, Inc. announced on April 23, 2025, the successful completion and launch of phases one through five of its proprietary virtual clinic and digital research ecosystem. This fully operational AI-integrated system was launched at the University of California, San Diego (UCSD) to support patient recruitment in the recently announced TBI / PTSD military study.
The virtual platform is designed to manage real-time data capture, remote monitoring, and clinical oversight of its HALO™ headset in both research and patient treatment settings. It allows civilian and military patients to receive treatment in the privacy of their homes while monitoring and validating compliance with clinical research protocols.
This milestone builds upon Phase 1, announced in December 2024, which introduced key components like the Electronic Data Capture (EDC) platform and Patient Monitoring System (PMS). The expanded digital ecosystem provides a comprehensive, technology-driven approach to treatment, crucial for advancing regulatory approvals and accelerating commercialization efforts for HALO™ and future DIFS™ technology applications.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.